Full Text
Analyzing eq-5d in phase 3 clinical trials of type 2 diabetes mellitus (t2dm)- is mean change capturing patient impact?

Abstract

Authors

A. Slee S. Traina C. Neslusan

Back to Volume 18, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×